Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age25-80
SponsorM.D. Anderson Cancer Center

About this trial

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Eligibility criteria

Qualifiers

Willingness to participate in the study and ability to provide informed consent

Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits

Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.

Disqualifiers

Current or recent (within the prior 6 months) history of breast feeding

Personal history of breast cancer (ductal breast carcinoma in situ [DCIS] or invasive breast cancer)

Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Trial design

Treatments tested in this trial

  • Biospecimen Collection
  • Mammography
  • Questionnaire Administration

Treatment groups

10,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator